Orexin-A in Patients With Lewy Body Disease: A Systematic Review and Meta-Analysis

BACKGROUND: Abnormal orexin-A levels in cerebrospinal fluid (CSF) have been identified in Alzheimer’s disease (AD) and other neurodegenerative diseases. However, few studies have focused on Lewy body disease (LBD) and often with debatable outcomes. Thus, we performed this systematic review and meta-...

Descripción completa

Detalles Bibliográficos
Autores principales: Gan, Jinghuan, Chen, Zhichao, Han, Jiuyan, Ma, Lingyun, Liu, Shuai, Wang, Xiao-Dan, Ji, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8635768/
https://www.ncbi.nlm.nih.gov/pubmed/34867809
http://dx.doi.org/10.3389/fendo.2021.765701

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8635768/
https://www.ncbi.nlm.nih.gov/pubmed/34867809
http://dx.doi.org/10.3389/fendo.2021.765701

Ejemplares similares